The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study)JOURNAL OF HYPERTENSIONIF4.12024-09-192PRE
EFFECT OF SEMAGLUTIDE VERSUS OTHER GLP-1 RECEPTOR AGONISTS ON OFFICE BLOOD PRESSURE LEVELS AMONG SUBJECTS WITH TYPE 2 DIABETES: A META-ANALYSISJOURNAL OF HYPERTENSIONIF4.12024-05-010OA
EFFECT OF GLP-1 RECEPTOR AGONISTS ON OFFICE BLOOD PRESSURE LEVELS AMONG OVERWEIGHT OR OBESE SUBJECTS TREATED WITH ANTIPSYCHOTIC DRUGS: A META-ANALYSISJOURNAL OF HYPERTENSIONIF4.12024-05-010OA
EFFECT OF TIRZEPATIDE ON OFFICE BLOOD PRESSURE LEVELS IN OVERWEIGHT OR OBESE INDIVIDUALS WITHOUT TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSISJOURNAL OF HYPERTENSIONIF4.12024-05-010OA
The Impact of Metabolic Syndrome Components on Erectile Function in Patients with Type 2 DiabetesMETABOLITESIF3.72023-04-303OAAI
Effect of sodium-glucose co-transporter-2 inhibitors on right ventricular function in patients with type 2 diabetes mellitus: A pilot studyKARDIOLOGIA POLSKAIF3.72022-06-302OA
Impact of Primary Aldosteronism in Resistant HypertensionCURRENT HYPERTENSION REPORTSIF5.12022-04-212PRE
Suboptimal management of dyslipidemia in everyday clinical practice: Alarming signals from real-world dataINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22020-10-013OAAI
Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical DisparitiesCURRENT HYPERTENSION REPORTSIF5.12020-09-1036OAAI
COVID-19: The Waterloo of governments, healthcare systems, and large health organizationsEUROPEAN JOURNAL OF INTERNAL MEDICINEIF6.12020-07-016OAAI
Coronary angiography and acute kidney injury: The dawn for novel markersINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22020-04-010PREAI
Update of the position paper on arterial hypertension and erectile dysfunction关于动脉高血压和勃起功能障碍的立场文件的更新JOURNAL OF HYPERTENSIONIF4.12020-02-1838PREAI
Coronary angiography and acute kidney injury: The dawn for novel markersINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22020-02-010PREAI
Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of randomized controlled trialsDIABETES RESEARCH AND CLINICAL PRACTICEIF7.42019-12-0119PREAI
Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonistsPOLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJIF4.72019-09-301OA
Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular diseaseCLINICAL AND MOLECULAR HEPATOLOGYIF16.92019-09-250OAAI
HYPERTENSION AND HEART FAILURE WITH MID-RANGE EJECTION FRACTION: A COMPARATIVE APPROACH IN HEART FAILURE SUBGROUPSJOURNAL OF HYPERTENSIONIF4.12019-07-010OAAI
IS THERE AN ASSOCIATION BETWEEN HYPERTENSION AND RIGHT VENTRICULAR DIASTOLIC FUNCTION IN HEART FAILURE PATIENTS?JOURNAL OF HYPERTENSIONIF4.12019-07-010OAAI
HYPERTENSION AND ERECTILE DYSFUNCTION: NEW INSIGHTS IN HEART FAILURE PATIENTSJOURNAL OF HYPERTENSIONIF4.12019-07-011PREAI
HYPERTENSION AND ANTIHYPERTENSIVE THERAPY IN HF PATIENTS ACCORDING TO GENDERJOURNAL OF HYPERTENSIONIF4.12019-07-010OAAI